Lin Hui Cai
Corporate Officer/Principal presso Xiamen LP Pharmaceutical Co., Ltd.
Profilo
Lin Hui Cai currently works at Xiamen LP Pharmaceutical Co., Ltd., as Deputy General Manager from 2020.
Ms. Cai received her graduate degree in 2011 from the University of Science & Technology Beijing.
Posizioni attive di Lin Hui Cai
| Società | Posizione | Inizio |
|---|---|---|
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Corporate Officer/Principal | 13/11/2020 |
Formazione di Lin Hui Cai
| University of Science & Technology Beijing | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |
- Borsa valori
- Insiders
- Lin Hui Cai
